STOCK TITAN

Bobak Azamian (TARS) files Rule 144 to sell 11,667 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Bobak Azamian reports proposed sale of common stock under Rule 144. The filing lists 11,667 common shares associated with Fidelity Brokerage Services LLC on 03/18/2026. The filing also discloses a prior sale of 10,972 shares on 03/17/2026 for $761,618.09.

The securities to be sold are listed as resulting from restricted stock vesting and are labeled compensation on 03/17/2026. Timing and exact sale methods are not detailed in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice for sale of vested restricted shares; prior open-market sale disclosed.

The filing lists 11,667 common shares associated with Fidelity Brokerage Services LLC dated 03/18/2026

It separately records a sale of 10,972 shares on 03/17/2026 for $761,618.09. The disclosure ties the new shares to restricted stock vesting and classifies them as compensation, which can affect Rule 144 availability rules and holding period calculations.

Transaction is routine insider liquidity following vesting; no material company-level event shown.

The filing shows an intended resale under Rule 144 for vested shares and a recent reported sale on 03/17/2026. The prior sale generated $761,618.09, indicating the transaction scale.

Cash‑flow treatment and distribution method are not stated in the excerpt; subsequent filings would show execution details or confirmations of sale.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TARS Form 144 filing disclose?

It discloses a proposed sale of 11,667 common shares and a recent sale of 10,972 shares. The prior sale occurred on 03/17/2026 for $761,618.09, and the new shares are linked to restricted stock vesting.

Who reported the sale in the TARS Form 144 filing?

The filing identifies Bobak Azamian as the reporting person and lists Fidelity Brokerage Services LLC in connection with 11,667 shares. The sale on 03/17/2026 of 10,972 shares is attributed to the same filer.

What security type and reason are listed in the TARS Form 144?

The security is Common stock and the securities to be sold are described as resulting from restricted stock vesting for compensation on 03/17/2026, per the excerpt.

How much proceeds were reported for the recent TARS sale?

The filing shows proceeds of $761,618.09 tied to the sale of 10,972 shares on 03/17/2026. No further allocation or use of proceeds is described in the excerpt.

Does the TARS filing state how the new shares will be sold?

No. The excerpt lists the shares as subject to Rule 144 resale but does not specify sale methods, brokers, or timing beyond the listed dates. Execution details are not present in the provided text.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

View TARS Stock Overview

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.90B
40.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
IRVINE